摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-二氟-3-三氟甲基溴苯 | 124170-06-5

中文名称
2,4-二氟-3-三氟甲基溴苯
中文别名
2-氟-5-(三氟甲氧基)硝基苯;3-硝基-4-氟三氟甲氧基苯
英文名称
1-fluoro-2-nitro-4-(trifluoromethoxy)benzene
英文别名
——
2,4-二氟-3-三氟甲基溴苯化学式
CAS
124170-06-5
化学式
C7H3F4NO3
mdl
——
分子量
225.099
InChiKey
XWFNBCCMBGKMFB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    234.7±35.0℃ (760 Torr)
  • 密度:
    1.543±0.06 g/cm3 (20 ºC 760 Torr)
  • 闪点:
    95.7±25.9℃

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    55
  • 氢给体数:
    0
  • 氢受体数:
    7

安全信息

  • 海关编码:
    2909309090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险性防范说明:
    P261,P301+P310,P305+P351+P338
  • 危险品运输编号:
    2810
  • 危险性描述:
    H301,H315,H319,H335
  • 储存条件:
    室温且干燥

SDS

SDS:ce34e6a55307a498f4f99427b8820fdf
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-Fluoro-2-nitro-4-(trifluoromethoxy)benzene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-Fluoro-2-nitro-4-(trifluoromethoxy)benzene
CAS number: 124170-06-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H3F4NO3
Molecular weight: 225.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis and QSAR of Herbicidal 3-Pyrazolyl α,α,α-Trifluorotolyl Ethers
    摘要:
    Pyrazole nitrophenyl ethers (PPEs) were recently identified as a novel class of chemistry exerting herbicidal effects by inhibition of protoporphyrinogen IX oxidase. This area of chemistry has been extended to include herbicidal pyrazolyl fluorotolyl ethers. In these compounds, a trifluoromethyl group substitutes for the 4'-nitro group found in the original herbicides and in ''classical'' nitrodiphenyl ether hebicides. Fluoroanisole pyrazole ethers, in which a trifluoromethoxy group replaces the nitro group of diphenyl ether herbicides, are also described. The shift from 4'-nitro to 4'-trifluoromethyl substitution, which is conservative in terms of electrostatics, produced a novel class of herbicide with substantial pre-emergent activity on narrowleaf weed species. Quantitative structure/activity relationships obtained with respect to substitution on the pyrazole ring and at the 3'-position of the fluorotolyl moiety can be summarized effectively by comparative molecular field analysis. In general, 5-methanesulfonyl fluorotoluidide ethers were found to be most active.
    DOI:
    10.1021/jf9601978
  • 作为产物:
    描述:
    4-三氟甲氧基氟苯 以54%的产率得到
    参考文献:
    名称:
    MARHOLD ALBRECHT
    摘要:
    DOI:
  • 作为试剂:
    描述:
    硝酸4-三氟甲氧基氟苯 、 在 硫酸乙酸乙酯2,4-二氟-3-三氟甲基溴苯 作用下, 反应 0.5h, 以to give a mixture (6.05 g) of 4-fluoro-2-nitro-1-trifluoromethoxy-benzene and 1-fluoro-2-nitro-4-trifluoromethoxy-benzene in a 3:1 ratio的产率得到4-氟-2-硝基-1-(三氟甲氧基)苯
    参考文献:
    名称:
    DIAMINOTRIAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES
    摘要:
    本发明涉及蛋白激酶抑制剂。该发明还提供了包含本发明化合物的药物组合物以及使用该组合物治疗各种疾病的方法。
    公开号:
    US20080014189A1
点击查看最新优质反应信息

文献信息

  • Heterocyclic compounds
    申请人:Zeneca Limited
    公开号:US05451594A1
    公开(公告)日:1995-09-19
    The invention provides compounds of formula (I) having nematicidal, insecticidal, acaricidal and fungicidal properties, compositions comprising them and processes and intermediates for their preparation: ##STR1## wherein: X is oxygen or sulphur; n is 0, 1 or 2; R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are as described in the specification.
    该发明提供具有杀线虫、杀虫、杀螨和杀菌性质的公式(I)化合物,包含它们的组合物以及它们的制备过程和中间体:##STR1## 其中:X是氧或硫;n是0、1或2;R.sup.1、R.sup.2、R.sup.3和R.sup.4如说明书中所描述。
  • NOVEL HETEROCYCLIC COMPOUND
    申请人:DAEWOONG PHARMACEUTICAL CO., LTD.
    公开号:US20170088551A1
    公开(公告)日:2017-03-30
    The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.
    本发明涉及一种化学式1所代表的化合物,可用于预防和治疗由脯氨酰-tRNA合成酶(PRS)活性异常引起的疾病,或其药用盐,以及制备该化合物的方法和包含该化合物的药物组合物。
  • [EN] DISUBSTITUTED [4-(5-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-1H-INDOL-3-YL]-METHANONES<br/>[FR] [4-(5-AMINOMÉTHYL-PHÉNYL)-PIPÉRIDIN-1-YL]-1H-INDOL-3-YL]-MÉTHANONES DISUBSTITUÉES
    申请人:SANOFI AVENTIS
    公开号:WO2011022449A1
    公开(公告)日:2011-02-24
    The present invention extends to the compound of formula I: or a prodrug, pharmaceutically acceptable salt, or solvate of said compound. Furthermore, the present invention is directed to a pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula I, and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed to the use of a compound of formula I as an inhibitor of tryptase, comprising introducing the compound into a composition comprising tryptase. In addition, the present invention is directed to the use of a compound of formula I for treating a patient suffering from, or subject to, a physiological condition in need of amelioration of an inhibitor of tryptase comprising administering to the patient a therapeutically effective amount of the compound of Claim 1. The present invention is directed also to the preparation of a compound of formula I.
    本发明涉及到式I的化合物:或者该化合物的前药、药用可接受的盐或溶剂。此外,本发明涉及一种包括式I化合物的药物组合物,以及药用可接受的载体的药学有效量。此外,本发明涉及将式I化合物用作色氨酸蛋白酶抑制剂的用途,包括将该化合物引入含有色氨酸蛋白酶的组合物中。此外,本发明还涉及将式I化合物用于治疗患有或患有需要改善色氨酸蛋白酶抑制剂的生理状况的患者的用途,包括向患者施用权利要求1中的化合物的治疗有效量。本发明还涉及制备式I化合物。
  • [EN] C-ABL TYROSINE KINASE INHIBITORY COMPOUND EMBODIMENTS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉ INHIBITEUR DE TYROSINE KINASE C-ABL, MODES DE RÉALISATION, PROCÉDÉS DE FABRICATION ET D'UTILISATION ASSOCIÉS
    申请人:US HEALTH
    公开号:WO2019173761A1
    公开(公告)日:2019-09-12
    Disclosed herein are embodiments of a compound that inhibits c-Abl tyrosine kinase (also referred to herein as "c-Abl"). The compound embodiments described herein are novel c-Abl inhibitors that can bind to c-Abl at an allosteric site and inhibit its activity in various pathways. The compound embodiments also are capable of crossing the blood brain barrier and therefore are useful in inhibiting c-Abl activity as it affects pathways and/or proteins in the brain. The compound embodiments described herein are effective therapeutic agents for treating diseases involving c-Abl, such as cancers, motor neuron diseases, and neurodegenerative diseases. Also disclosed herein are embodiments of methods for making and using the c- Abl inhibitory compound embodiments.
    本文披露了一种抑制c-Abl酪氨酸激酶(本文中也称为"c-Abl")的化合物实施例。本文描述的这些化合物实施例是新颖的c-Abl抑制剂,可以结合到c-Abl的一个变构位点,并在各种途径中抑制其活性。这些化合物实施例还能够穿过血脑屏障,因此在抑制影响大脑途径和/或蛋白质的c-Abl活性方面是有用的。本文描述的这些化合物实施例是治疗涉及c-Abl的疾病的有效治疗剂,如癌症、运动神经元疾病和神经退行性疾病。本文还披露了制备和使用c-Abl抑制化合物实施例的方法实施例。
  • 一种微波促进N-苯磺酰基硝基苯胺类化合物合成的方法
    申请人:邵阳学院
    公开号:CN108997177A
    公开(公告)日:2018-12-14
    本发明公开了一种微波促进N‑苯磺酰基硝基苯胺类化合物合成的方法;本发明涉及化学合成技术。本发明采用微波辐射的方式,以廉价易得的取代苯磺酰胺和取代卤代硝基苯为原料在缚酸剂的作用下高效高收率的合成N‑苯磺酰基硝基苯胺,该合成反应缩短了反应步骤、提高了收率,可用于快速合成式(Ⅰ)所示N‑苯磺酰基硝基苯胺类化合物。本发明的一种微波促进N‑苯磺酰基硝基苯胺类化合物合成的方法,成本低、操作简单、效率高、收率高、并且降低了硝化反应带来的环境污染问题,具有较高应用价值和经济效益。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐